ML

Michael Lee

Board Member at Fate Therapeutics

Mr. Lee is a co-founder and portfolio manager at Redmile Group, LLC, a healthcare-focused investment firm based in San Francisco and New York. Prior to Redmile, he worked as a biotechnology investor at Steeple Capital, and before that at Welch Capital Partners and Prudential Equity Group. Mike holds a B.S. in Molecular and Cellular Biology from the University of Arizona.